Apollo Medical Holdings Inc
NASDAQ:ASTH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Apollo Medical Holdings Inc
NASDAQ:ASTH
|
US |
|
EDP Renovaveis SA
OTC:EDRVY
|
ES |
|
Reliance Home Finance Ltd
NSE:RHFL
|
IN |
|
Qrf Comm Va
F:2QR
|
BE |
|
HBL Engineering Ltd
NSE:HBLENGINE
|
IN |
|
S
|
Sky Gold Ltd
BSE:541967
|
IN |
|
Tesoro Resources Ltd
ASX:TSO
|
AU |
|
Freedom Holding Corp
NASDAQ:FRHC
|
US |
|
T
|
Tripadvisor Inc
SWB:T6A
|
US |
Wall St Price Targets
ASTH Price Targets Summary
Apollo Medical Holdings Inc
According to Wall Street analysts, the average 1-year price target for ASTH is 44.43 USD with a low forecast of 37.37 USD and a high forecast of 52.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ASTH's stock price target?
Price Target
44.43
USD
According to Wall Street analysts, the average 1-year price target for ASTH is 44.43 USD with a low forecast of 37.37 USD and a high forecast of 52.5 USD.
What is the Revenue forecast for Apollo Medical Holdings Inc?
Projected CAGR
11%
Over the last 4 years, the compound annual growth rate for Revenue has been 42%. The projected CAGR for the next 6 years is 11%.
What is the Operating Income forecast for Apollo Medical Holdings Inc?
Projected CAGR
25%
Over the last 4 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 6 years is 25%.
What is the Net Income forecast for Apollo Medical Holdings Inc?
Projected CAGR
65%
Over the last 4 years, the compound annual growth rate for Net Income has been -24%. The projected CAGR for the next 3 years is 65%.
